Carlyle to exit China’s Concord Medical via founder-led privatization
The Carlyle Group is set to make a full exit from Concord Medical Services, a US-listed Chinese radiotherapy and diagnostic imaging center operator, in a take-private transaction initiated by the company’s chairman and CEO.
According to a statement, the founder-led proposed acquisition was priced at $1.73 per Class A ordinary share, or $5.19 per American Depository Share. This represents a premium of 33.8% to the company's...
More on Greater China
Latest News
Asia IPOs gone cold: India edition
A compilation of India-based IPOs - some of them private equity-backed - that have been withdrawn or appear to have fallen behind schedule
China LiDAR specialist Hesai aims for US IPO
Hesai Technology, a China-based developer of sensors used in autonomous driving, is targeting a US listing. Its investors include Lightspeed China Partners, Baidu, Bosch, and Xiaomi.
Indonesia fintech start-up iSeller gets $12m
Indonesia financial technology start-up iSeller, which helps businesses to digitise sales and operations, has raised USD 12m in Series B funding led by Intudo Ventures.
Hillhouse-backed China pet services business seeks US listing
New Ruipeng Pet Group, a China-based pet care services platform that counts Hillhouse Capital as a significant shareholder, has filed for an IPO in the US.